CPC C12N 5/0696 (2013.01) [A61K 35/545 (2013.01); C12N 15/86 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/999 (2013.01); C12N 2502/1114 (2013.01)] | 12 Claims |
1. A method of producing human induced pluripotent stem cells (iPSCs) comprising:
a) contacting and culturing an isolated population of cells comprising γδ T cells with an activation culture to activate and enrich Vγ9Vδ2 γδ T cells within the isolated population of cells; wherein the activation culture comprises IL-15 and zoledronic acid;
b) after step (a), purifying the Vγ9Vδ2-enriched γδ T cells from the isolated population of cells;
c) transducing the purified Vγ9Vδ2-enriched γδ T cells with a viral vector encoding one or more reprogramming factors; and
d) culturing the transduced cells under conditions suitable for reprogramming mammalian somatic cells to a pluripotent state, thereby producing iPSCs;
wherein the produced iPSCs have rearranged TRG and TRD genes;
wherein the produced iPSCs have TCR rearrangements containing Vγ9 and Vδ2 gene segments;
wherein optionally the activation culture further comprises IL-2;
wherein optionally the viral vector is a Sendai virus (SeV) vector;
wherein optionally the method further comprises obtaining the isolated population of cells from a subject prior to step (a); and
wherein optionally the isolated population of cells are peripheral blood mononuclear cells (PBMCs).
|